Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 228,768,667 papers from all fields of science
Search
Sign In
Create Free Account
Celebrex
a kind of arthritis drug
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Broader (2)
Anti-Inflammatory Agents, Non-Steroidal
celecoxib
SC 58635
celecoxib 100 MG Oral Capsule [Celebrex]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
The role of celecoxib in Rad51 expression and cell survival affected by gefitinib in human non-small cell lung cancer cells.
J. Ko
,
Lyu-Han Wang
,
+4 authors
Yun-Wei Lin
Lung Cancer
2009
Corpus ID: 206747965
2005
2005
A Thrombelastograph whole blood assay for clinical monitoring of NSAID-insensitive transcellular platelet activation by arachidonic acid.
R. Carroll
,
R. Craft
,
J. J. Chavez
,
C. C. Snider
,
S. Bresee
,
E. Cohen
Journal of Laboratory and Clinical Medicine
2005
Corpus ID: 21048372
2004
2004
Assessment of cyclooxygense-2 expression with 99mTc-labeled celebrex
David J. Yang
,
J. Bryant
,
+9 authors
D. Podoloff
Anti-Cancer Drugs
2004
Corpus ID: 9664859
Cyclooxygenase-2 (COX-2) plays an important role in angiogenesis and cancer progression. Since many tumor cells exhibit COX-2…
Expand
Review
2004
Review
2004
Halt of Celebrex Study Threatens Drug's Future, Other Trials
J. Couzin
Science
2004
Corpus ID: 30054154
New research indicates Pfizer9s COX-2 inhibitor Celebrex may cause increased risk of heart attacks and strokes, leading to the…
Expand
2004
2004
Characteristics of COX2 inhibitors questioned
S. Petit-Zeman
Nature reviews. Drug discovery
2004
Corpus ID: 1104653
A health watchdog agency's decision on COX2 inhibitors highlights the difference in opinion about the use of these treatments.
2003
2003
4-substituted 1,5-diarylpyrazole, analogues of celecoxib: synthesis and preliminary evaluation of biological properties.
G. Menozzi
,
L. Merello
,
P. Fossa
,
L. Mosti
,
A. Piana
,
F. Mattioli
Il Farmaco
2003
Corpus ID: 32307227
Review
2003
Review
2003
Initial Experience Combining Cyclooxygenase-2 Inhibition with Chemoradiation for Locally Advanced Pancreatic Cancer
C. Crane
,
K. Mason
,
N. Janjan
,
L. Milas
American Journal of Clinical Oncology
2003
Corpus ID: 5630244
Pancreatic cancer is a lethal disease that is resistant to chemotherapy and radiotherapy. Gemcitabine has recently been shown to…
Expand
2003
2003
[Severe cutaneous drug reactions to celecoxib (Celebrex)].
S. Marques
,
B. Milpied
,
P. Foulc
,
S. Barbarot
,
E. Cassagnau
,
J. Stalder
Annales de dermatologie et de vénéréologie
2003
Corpus ID: 42743594
INTRODUCTION Celecoxib (Celebrex) is a Cox 2 selective non steroidal anti-inflammatory agent. Adverse reactions reported are…
Expand
Highly Cited
2002
Highly Cited
2002
Stability-indicating methods for the determination of doxazosin mezylate and celecoxib.
L. I. Bebawy
,
A. Moustafa
,
N. F. Abo-Talib
Journal of Pharmaceutical and Biomedical Analysis
2002
Corpus ID: 31535117
2002
2002
What's all the fuss? Safety concerns about COX-2 inhibitors rofecoxib (Vioxx) and celecoxib (Celebrex).
E. Wooltorton
CMAJ : Canadian Medical Association journal…
2002
Corpus ID: 26162245
Reason for posting: NSAIDs are useful in the treatment of several musculoskeletal conditions[1][1] and primary dysmenorrhea,[2][2…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE